Status: Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
The purpose of this clinical trial is to measure the safety and efficacy of RTN-001 in adult participants with uncontrolled hypertension versus placebo.
Participants needed: 280
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Retension Pharmaceuticals. Inc.Updated: Oct 2, 2026Locations: 34
Eligibility criteria
Male or female patients age 18 to 75 years, inclusive, at the Screening Visit. [+3]
Mean seated SBP >175 mm Hg and/or DBP >110 mm Hg. [+19]